Clinical Trial Update: Efficacy and Safety of Surinabant Treatment as an Aid to Smoking Cessation (SURSMOKE) [Phase 2]

View source ↗

Summary

Phase 2 results evaluating Surinabant as an aid to smoking cessation, reporting efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Surinabant (Surinabant)

Snippet

Sponsor: Sanofi | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED